Advertisements


What"s Ahead For Axsome Therapeutics?

What"s Ahead For Axsome Therapeutics?.....»»

Category: topSource: seekingalphaJan 12th, 2019

Axsome Therapeutics: Still 5 Catalysts Ahead In 2019

Axsome Therapeutics: Still 5 Catalysts Ahead In 2019.....»»

Category: topSource: seekingalphaJan 7th, 2019

What"s Ahead For Axsome Therapeutics?

What"s Ahead For Axsome Therapeutics?.....»»

Category: topSource: seekingalphaJan 12th, 2019

Axsome Therapeutics: Assessing If There"s Upside Left After Big Run

Axsome Therapeutics: Assessing If There"s Upside Left After Big Run.....»»

Category: topSource: seekingalphaJun 5th, 2019

Revisiting Axsome After Its 800% Year-To-Date Rally

Axsome Therapeutics Inc (NASDAQ: AXSM) stock has been a high flier ever since it hit a record intraday low of $1.94 in late December. read more.....»»

Category: blogSource: benzingaMay 30th, 2019

Axsome Therapeutics price target raised to $35 from $25 at Cantor Fitzgerald

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 28th, 2019

Axsome Therapeutics initiated with a Buy at SunTrust

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 28th, 2019

Axsome Therapeutics initiated at buy with $50 price target at SunTrust Robinson Humphrey

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 28th, 2019

Axsome Therapeutics price target raised to $30 from $23 at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 23rd, 2019

Capricor Therapeutics (CAPR) Reports Q1 Loss, Lags Revenue Estimates

Capricor (CAPR) delivered earnings and revenue surprises of 27.27% and -42.25%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zacks Inve.....»»

Category: smallbizSource: nytMay 13th, 2019

Insys Therapeutics (INSY) Reports Q1 Loss, Lags Revenue Estimates

Insys Therapeutics (INSY) delivered earnings and revenue surprises of -323.08% and -48.96%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zacks I.....»»

Category: dealsSource: nytMay 10th, 2019

Axsome Therapeutics, Inc. (AXSM) CEO Dr. Herriot Tabuteau on Q1 2019 Results - Earnings Call Transcript

Axsome Therapeutics, Inc. (AXSM) CEO Dr. Herriot Tabuteau on Q1 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 10th, 2019

Axsome Therapeutics reports Q1 EPS (32c), consensus (30c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 9th, 2019

4 Stocks Breaking Out On Earnings & Other News

Here are four stocks to watch with strong technical momentum fueled by earnings and other news. Axsome Therapeutics, Inc. (NASDAQ.....»»

Category: earningsSource: benzingaMay 8th, 2019

Axsome Shares Rally After FDA OKs Expedited Regulatory Filings For Depression Drug

Axsome Therapeutics Inc (NASDAQ: AXSM) has been a standout performer among biotech stocks year-to-date. read more.....»»

Category: blogSource: benzingaMay 6th, 2019

Axsome Therapeutics: AXS-05"s Potential In Nicotine Addiction

Axsome Therapeutics: AXS-05"s Potential In Nicotine Addiction.....»»

Category: topSource: seekingalphaApr 24th, 2019

Amicus Therapeutics: Looking A Few Years Ahead

Amicus Therapeutics: Looking A Few Years Ahead.....»»

Category: topSource: seekingalphaApr 18th, 2019

Axsome Therapeutics price target raised to $23 from $18 at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Axsome Therapeutics initiated with an Outperform at SVB Leerink

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 8th, 2019

Axsome Therapeutics started at outperform with $25 stock price target at SVB Leerink

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 8th, 2019

Axsome Therapeutics price target raised to $25 from $20 at BTIG

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 28th, 2019